What's Helping What We Do?

These are the positive forces at work in our strategy/ program that influence how much we do or how well we do it.

• County Leadership support
• Collaborate work with Community Paramedic from Chatuge Family Practice  
• Monoclonal Antibodies medication being free 
• The use of the Senior Center facility
• The Community Paramedic program at Clay County Health Department
• Social Media outreach to inform the community
• Covid-19 testing at our facility
• Following up after infusion for extra guideance if needed

What's Hurting What We Do?

These are the negative forces at work in our strategy/program that influence how much we do or how well we do it.

•  Limited supply for allocations to local health department
•   Supplies on backorder
•   The change in approved infusion medications
•   Stigma surrounding efficacy and safety of infusions
•   The delay in Covid test results

The following actions have been identified by CHA Team as ideas for what can work for this performance measure to make a difference on Prevention and Management of Acute Respiratory Infections.

(A) Actions and Approaches Identified by Our CHA Team. These are actions and approaches that we think can make a difference for this performance measure.

• Influenza, Pneumonia, and COVID-19 vaccines to help decrease the effects from these viruses
• Monoclonal Antibody treatment
• Early detection of an illness
• Proper use of an incentive spirometer
• Information/education on these infections

(B) No-cost and Low-cost Ideas Identified by Our CHA Team. These are no-cost and low-cost actions and approaches that we think can make a difference for this performance measure.

• Providing education to individuals about signs of Respiratory Distress
• Immunizations are covered by most insurance companies

(C) What your customers think would work to do better. These are actions and approaches that our customers think can make a difference for this performance measure.

• Increase vaccinations
• Monoclonal Antibodies

(D) List of Questions/Research Agenda These are questions to follow-up on for this performance measure. 

• Did we see an improvement with patients after receiving Monoclonal Antibodies?
• Does vaccines lessen the effects of these respiratory illnesses?
• Does early detection make a difference with treatment?